Immunophenotype and evolution of breast carcinomas: A comparison between very young and postmenopausal women;Imunofenótipo e evolução de câncer de mama: Comparação entre mulheres muito jovens e mulheres na pós-menopausa

Revista Brasileira de Ginecologia e Obstetricia

Volumn 31, Issue 2, 2009, Pages 54-60

  Dutra, Mara Costa ^a   Rezende, Marina Alvarenga ^a   Andrade, Victor Piana de ^b   Soares, Fernando Augusto ^c   Ribeiro, Márcio Ventura ^d   Paula, Élbio Cândido de ^e   Gobbi, Helenice ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Departamento de Anatomia Patológica do Hospital do Câncer   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d A C CAMARGO CANCER CENTER   (Brazil)

^e FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Age groups; Breast neoplasms diagnosis; Breast neoplasms pathology; Immunohistochemistry; Immunophenotyping; Prognosis; Survival rate; Tumor markers, biological; Women

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREAST TUMOR; COMPARATIVE STUDY; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; MIDDLE AGED; POSTMENOPAUSE;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOPHENOTYPING; MIDDLE AGED; POSTMENOPAUSE; YOUNG ADULT;

EID: 66649137392     PISSN: 01007203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Yau C, Fedele V, Roydasgupta R, Fridlyand J, Hubbard A, Gray JW, et al. Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers. Breast Cancer Res. 2007;9(5):R59.
2. Gonzalez-Angulo AM, Broglio K, Kau SW, Eralp Y, Erlichman J, Valero V, et al. Women age ≤35 years with primary breast carcinoma: disease features at presentation. Cancer. 2005;103(12): 2466-72.
3. Walker RA, Lees E, Webb MB, Dearing SJ. Breast carcinomas occurring in young women (<35 years) are different. Br J Cancer. 1996;74(11):1796-800.
4. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA. 2003;100(14):8418-23.
5. El Saghir NS, Seoud M, Khalil MK, Charafeddine M, Salem ZK, Geara BF, et al. Effects of young age at presentation on survival in breast cancer. BMC Cancer. 2006;6:194.
6. Elkum N, Dermime S, Ajarim D, Al-Zahrani A, Alsayed A, Tulbah A, et al. Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: the Saudi Arabia experience. BMC Cancer. 2007;7:222.
7. Kollias J, Elston CW, Ellis IO, Robertson JF, Blamey RW. Early-onset breast cancer - histopathological and prognostic considerations. Br J Cancer. 1997;75(9):1318-23.
8. Peppercorn J, Partridge AH. Breast cancer in young women: a new color or a different shade of pink. J Clin Oncol. 2008;26(20):3303-5.
9. Aebi S. Special issues related to the adjuvant therapy in very young women. Breast. 2005;14(6):594-9.
10. Fernandopuplle SM, Cher-Siangang P, Tan PH. Breast carcinoma in women 35 years and younger: A pathological study. Pathology. 2006;38(3):219-22.
11. Yankaskas BC. Epidemiology of breast cancer in young women. Breast Dis. 2005-2006;23:3-8.
12. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747-52.
13. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression atterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001;98(19):10869-74.
14. Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res. 2004;10(16):5367-74.
15. Rakha EA, El-Sayed ME, Green AR, Paish EC, Lee AH, Ellis IO. Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression. Histopathology. 2007;50(4):434-8.
16. Diaz LK, Cryns VL, Symmans WF, Sneige N. Triple negative breast carcinoma and the basal phenotype: from expression profiling to clinical practice. Adv Anat Pathol. 2007;14(6):419-30.
17. Page DL, Jensen RA, Simpson JF. Routinely available indicators of prognosis in breast cancer. Breast Cancer Res Treat. 1998;51(3):195-208.
18. Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM, et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000;124(7):966-78.
19. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19(5):403-10.
20. Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 1998;11(2):155-68.
21. Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendation for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007;25(1):118-45.
22. Jones C, Ford E, Gillett C, Ryder K, Merrett S, Reis-Filho JS, et al. Molecular cytogenetic identification of subgroups of grade III invasive ductal breast carcinomas with different clinical outcomes. Clin Cancer Res. 2004;10(18 Pt 1):5988-97.
23. Potemski P, Kusinska R, Watala C, Pluciennik E, Bednarek AK, Kordek R. Prognostic relevance of basal cytokeratin expression in operable breast cancer. Oncology. 2005;69(6):478-85.
24. Collett K, Stefansson IM, Eide J, Braaten A, Wang H, Eide GE, et al. A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors. Cancer Epidemiol Biomarkers Prev. 2005;14(5):1108-12.
25. Ribeiro-Silva A, Zambelli Ramalho LN, Britto Garcia S, Zucoloto S. The relationship between p63 and p53 expression in normal and neoplastic breast tissue. Arch Pathol Lab Med. 2003;127(3):336-40.
26. Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF, Ellis IO. Prognostic markers in triple-negative breast cancer. Cancer. 2007;109(1):25-32.
27. Rakha EA, Reis-Filho JS, Ellis IO. Impact of basal-like breast carcinoma determination for a more specific therapy. Pathobiology. 2008;75(2):95-103.
28. Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol. 2008;26(20):3324-30.